eflornithine has been researched along with Cardiomyopathy, Hypertrophic in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stephan, C | 1 |
| Just-Nuebling, G | 1 |
| Fichtlscherer, S | 1 |
| Kriener, S | 1 |
| Brodt, HR | 1 |
1 other study available for eflornithine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Winterbottom's sign and hypertrophic cardiomyopathy.
Topics: Adult; Animals; Cardiomyopathy, Hypertrophic; Diagnosis, Differential; Eflornithine; Humans; Lymphat | 2002 |